Disease-modifying strategies and challenges in PD: interactive breakout sessions.
D000367:Age Factors; D000978:Antiparkinson Agents / Q000009:adverse effects / Q000627:therapeutic use; D003863:Depression / Q000209:etiology; D019468:Disease Management; D018450:Disease Progression; D015259:Dopamine Agents / Q000009:adverse effects / Q000627:therapeutic use; D004358:Drug Therapy / Q000639:trends; D006801:Humans; D007024:Hypotension, Orthostatic / Q000209:etiology; D018696:Neuroprotective Agents / Q000627:therapeutic use; D010300:Parkinson Disease / Q000150:complications / Q000188:drug therapy* / Q000601:surgery; D012893:Sleep Wake Disorders / Q000209:etiology
D000978:Antiparkinson Agents; D015259:Dopamine Agents; D018696:Neuroprotective Agents